InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

NEUROCRINE BIOSCIENCES INC

NBIX Clue Score82
United States Fiscal year ends December CIK 0000914475
$142.44 +0.84% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $142.44 +37.20% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue15.0Operating income−147.4Net income−141.1EPS, diluted−1.63Fiscal year 2017Revenue161.6 +977.5%Operating income−131.4Net income−142.5EPS, diluted−1.62Fiscal year 2018Revenue451.2 +179.2%Operating income36.8Net income21.1EPS, diluted0.22Fiscal year 2019Revenue788.1 +74.7%Operating income72.3Net income37.0 +75.4%EPS, diluted0.39 +77.3%Fiscal year 2020Revenue1,045.9 +32.7%Operating income163.0Net income407.3 +1,000.8%EPS, diluted4.16 +966.7%Fiscal year 2021Revenue1,133.5 +8.4%Operating income102.5Net income89.6 −78.0%EPS, diluted0.92 −77.9%Fiscal year 2022Revenue1,488.7 +31.3%Operating income249.0Net income154.5 +72.4%EPS, diluted1.56 +69.6%Fiscal year 2023Revenue1,887.1 +26.8%Operating income250.9Net income249.7 +61.6%EPS, diluted2.47 +58.3%Fiscal year 2024Revenue2,355.3 +24.8%Operating income570.5Net income341.3 +36.7%EPS, diluted3.29 +33.2%Fiscal year 2025Revenue2,860.5 +21.4%Operating income619.1Net income478.6 +40.2%EPS, diluted4.67 +41.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 15.0 161.6 451.2 788.1 1,045.9 1,133.5 1,488.7 1,887.1 2,355.3 2,860.5
Growth +977.5% +179.2% +74.7% +32.7% +8.4% +31.3% +26.8% +24.8% +21.4%
Operating income −147.4 −131.4 36.8 72.3 163.0 102.5 249.0 250.9 570.5 619.1
Net income −141.1 −142.5 21.1 37.0 407.3 89.6 154.5 249.7 341.3 478.6
Growth +75.4% +1,000.8% −78.0% +72.4% +61.6% +36.7% +40.2%
EPS, diluted −1.63 −1.62 0.22 0.39 4.16 0.92 1.56 2.47 3.29 4.67
Growth +77.3% +966.7% −77.9% +69.6% +58.3% +33.2% +41.9%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−982.5%Net margin−940.6%Free cash flow margin−735.3%Fiscal year 2017Operating margin−81.3%Net margin−88.2%Free cash flow margin−62.7%Fiscal year 2018Operating margin8.2%Net margin4.7%Free cash flow margin17.0%Fiscal year 2019Operating margin9.2%Net margin4.7%Free cash flow margin16.8%Fiscal year 2020Operating margin15.6%Net margin38.9%Free cash flow margin20.8%Fiscal year 2021Operating margin9.0%Net margin7.9%Free cash flow margin20.6%Fiscal year 2022Operating margin16.7%Net margin10.4%Free cash flow margin21.7%Fiscal year 2023Operating margin13.3%Net margin13.2%Free cash flow margin19.2%Fiscal year 2024Operating margin24.2%Net margin14.5%Free cash flow margin23.7%Fiscal year 2025Operating margin21.6%Net margin16.7%Free cash flow margin26.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −982.5% −81.3% 8.2% 9.2% 15.6% 9.0% 16.7% 13.3% 24.2% 21.6%
Net margin −940.6% −88.2% 4.7% 4.7% 38.9% 7.9% 10.4% 13.2% 14.5% 16.7%
Free cash flow margin −735.3% −62.7% 17.0% 16.8% 20.8% 20.6% 21.7% 19.2% 23.7% 26.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−106.2Capital expenditure−4.1Free cash flow−110.3Fiscal year 2017Operating cash flow−94.3Capital expenditure−6.9Free cash flow−101.3Fiscal year 2018Operating cash flow101.4Capital expenditure−24.8Free cash flow76.6Fiscal year 2019Operating cash flow147.0Capital expenditure−14.7Free cash flow132.3 +72.7%Fiscal year 2020Operating cash flow228.5Capital expenditure−10.9Free cash flow217.6 +64.5%Fiscal year 2021Operating cash flow256.5Capital expenditure−23.4Free cash flow233.1 +7.1%Fiscal year 2022Operating cash flow339.4Capital expenditure−16.5Free cash flow322.9 +38.5%Buybacks0.0Fiscal year 2023Operating cash flow389.9Capital expenditure−28.3Free cash flow361.6 +12.0%Buybacks0.0Fiscal year 2024Operating cash flow595.4Capital expenditure−38.2Free cash flow557.2 +54.1%Buybacks−300.0Fiscal year 2025Operating cash flow782.7Capital expenditure−34.0Free cash flow748.7 +34.4%Buybacks−167.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −106.2 −94.3 101.4 147.0 228.5 256.5 339.4 389.9 595.4 782.7
Capital expenditure −4.1 −6.9 −24.8 −14.7 −10.9 −23.4 −16.5 −28.3 −38.2 −34.0
Free cash flow −110.3 −101.3 76.6 132.3 217.6 233.1 322.9 361.6 557.2 748.7
Growth +72.7% +64.5% +7.1% +38.5% +12.0% +54.1% +34.4%
Buybacks n/a n/a n/a n/a n/a n/a 0.0 0.0 −300.0 −167.7

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash83.3Shareholders’ equity314.9Fiscal year 2017Cash254.7Shareholders’ equity372.2Fiscal year 2018Cash141.7Shareholders’ equity480.8Fiscal year 2019Cash112.3Shareholders’ equity636.9Fiscal year 2020Cash187.1Shareholders’ equity1,126.2Fiscal year 2021Cash340.8Shareholders’ equity1,374.0Fiscal year 2022Cash262.9Shareholders’ equity1,707.8Fiscal year 2023Cash251.1Shareholders’ equity2,232.0Fiscal year 2024Cash233.0Shareholders’ equity2,589.7Fiscal year 2025Cash713.0Shareholders’ equity3,253.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 83.3 254.7 141.7 112.3 187.1 340.8 262.9 251.1 233.0 713.0
Shareholders’ equity 314.9 372.2 480.8 636.9 1,126.2 1,374.0 1,707.8 2,232.0 2,589.7 3,253.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
15.0 161.6 451.2 788.1 1,045.9 1,133.5 1,488.7 1,887.1 2,355.3 2,860.5
Growth +977.5% +179.2% +74.7% +32.7% +8.4% +31.3% +26.8% +24.8% +21.4%
0.0 1.3 4.9 n/a 10.1 14.3 23.2 39.7 34.0 52.1
94.3 121.8 160.5 n/a n/a n/a n/a n/a n/a n/a
68.1 169.9 248.9 354.1 433.3 583.3 752.7 887.6 1,007.2 1,156.2
−147.4 −131.4 36.8 72.3 163.0 102.5 249.0 250.9 570.5 619.1
Growth +96.5% +125.4% −37.1% +142.9% +0.8% +127.4% +8.5%
−141.1 −142.5 21.8 46.5 106.7 101.4 213.9 332.1 486.0 705.4
0.0 0.0 0.7 9.5 −300.6 11.8 59.4 82.4 144.7 226.8
−141.1 −142.5 21.1 37.0 407.3 89.6 154.5 249.7 341.3 478.6
Growth +75.4% +1,000.8% −78.0% +72.4% +61.6% +36.7% +40.2%
Per share
−1.63 −1.62 0.23 0.40 4.38 0.95 1.61 2.56 3.40 4.81
−1.63 −1.62 0.22 0.39 4.16 0.92 1.56 2.47 3.29 4.67
Growth +77.3% +966.7% −77.9% +69.6% +58.3% +33.2% +41.9%
86.7 88.1 90.2 91.6 93.1 94.6 95.8 97.7 100.4 99.5
86.7 88.1 95.4 95.7 97.8 97.9 98.9 101.0 103.7 102.5
Growth +1.6% +8.3% +0.3% +2.2% +0.1% +1.0% +2.1% +2.7% −1.2%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 22.3% a year over five years, and earnings per share grew 2.3% a year.
  • The diluted share count rose 4.8% in five years, which is dilution.
  • Operating margin is up 6.1 points on five years ago, at 21.6%.
  • A net loss in 2 of 10 years on file.